Combination therapy for solar lentigines.
Solar lentigines are benign, hyperpigmented lesions that present a significant cosmetic nuisance for many middle-aged and elderly patients with chronic accumulated sun exposure. While previous monotherapies designed to lighten these lesions offer relatively modest improvement, there are several new treatment options. Combination topical therapy using 2% mequinol/0.01% tretinoin [Solagé Topical Solution] has been shown to markedly reduce lesion darkness with few side effects. Chemical peels can give good results either alone or in combination with topical therapy. Cryotherapy is an effective and inexpensive way of treating solar lentigines while IPL and lasers are more costly treatment options. For patients desiring treatment, optimal cosmetic improvement can be achieved using a combination of topical and procedural therapies.
Farris
Patricia K
PK
D000279:Administration, Cutaneous; D002615:Chemexfoliation / Q000379:methods; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D017679:Cryotherapy / Q000379:methods; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D053685:Laser Therapy; D007911:Lentigo / Q000209:etiology / Q000523:psychology / Q000628:therapy*; D010789:Phototherapy / Q000379:methods; D013472:Sunlight / Q000009:adverse effects*; D016896:Treatment Outcome
D003879:Dermatologic Agents